The Value of Phase 4 Clinical Testing
- 26 January 2006
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 354 (4) , 413-415
- https://doi.org/10.1056/nejme058272
Abstract
Since its inception in 1988, the Multicenter Study of Perioperative Ischemia Research Group has examined a number of critical issues concerning the outcomes of cardiac surgery and anesthesia. The group's database is a powerful research tool. Its power derives from the high quality of the participating institutions, the capability of these institutions to recruit a large number of patients, and an absence of potential conflict of interest, in part due to the large number of participating institutions and investigators.In this issue of the Journal, Mangano et al.1 report the findings from a large clinical database built on the data-collection . . .Keywords
This publication has 6 references indexed in Scilit:
- The Risk Associated with Aprotinin in Cardiac SurgeryNew England Journal of Medicine, 2006
- cardiopulmonary bypass in patients?The Journal of Thoracic and Cardiovascular Surgery, 2003
- Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in childrenThe Annals of Thoracic Surgery, 1996
- Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusionThe Journal of Thoracic and Cardiovascular Surgery, 1993
- Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled studyThe Annals of Thoracic Surgery, 1992